Newsletter Archive
-
08.06.26 -- Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models
8/6/2026
08/06/26 Bioprocess Online Newsletter
-
08.05.26 -- Preparing For What's Next In Regulated Manufacturing
8/5/2026
08/05/26 Bioprocess Online Newsletter
-
08.05.26 -- Demonstrating Non-Inferiority Of BFPCs Vs. Traditional Air Monitoring
8/5/2026
08/05/26 Bioprocess Online Newsletter
-
08.04.26 -- De-Risk MSC Development From Source To Scale
8/4/2026
08/04/26 Bioprocess Online Newsletter
-
08.04.26 -- CDMO Capacity Remains Tight — How To Avoid A Costly Partner Mistake
8/4/2026
08/04/26 Bioprocess Online Newsletter
-
08.03.26 -- Cell Culture Media Solutions Driving Better Yield, Consistency, And Scale-Up
8/3/2026
08/03/26 Bioprocess Online Newsletter
-
08.03.26 -- Platform Strategies For Manufacturable Bispecific Antibodies
8/3/2026
08/03/26 Bioprocess Online Newsletter
-
08.03.26 -- Next-Generation Molecules Challenge Notions Of Yield And Performance
8/3/2026
08/03/26 Bioprocess Online Newsletter
-
07.31.26 -- STREAM Edition: On The Ground At BIO 2026: Johanna Kaufmann, Ph.D., On The Oncology Modality Puzzle
7/31/2026
07/31/26 Bioprocess Online Newsletter
-
07.31.26 -- Modulating Multispecific Manufacturability With AP Biosciences' JJ You, Ph.D.
7/31/2026
07/31/26 Bioprocess Online Newsletter